The metastasis associated protein S100A4: Role in tumour progression and metastasis

British Journal of Cancer

Volumn 92, Issue 11, 2005, Pages 1955-1958

  Helfman, D M ^a   Kim, E J ^b   Lukanidin, E ^c   Grigorian, M ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Angiogenesis; Apoptosis; Breast cancer; Invasion; Motility; Prognosis

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTINEOPLASTIC AGENT; CALCIUM BINDING PROTEIN; CALVASCULIN; CELL PROTEIN; COLLAGENASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA; LIPRIN BETA1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2B; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MYOSIN; MYOSIN HEAVY CHAIN; PROTEIN KINASE C; PROTEIN P53; PROTEIN S 100; PROTEIN S 100A12; PROTEIN S 100A13; PROTEIN S100B; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TRANSCRIPTION FACTOR; TROPOMYOSIN; TUBULIN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANGIOGENESIS; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MOTILITY; CLINICAL PROTOCOL; COLORECTAL CANCER; CORRELATION ANALYSIS; DIMERIZATION; ENDOTHELIUM CELL; ESOPHAGUS CANCER; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; GALLBLADDER CANCER; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MEDULLOBLASTOMA; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; ONCOGENE NEU; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RISK BENEFIT ANALYSIS; SHORT SURVEY; SIDE EFFECT; SIGNAL TRANSDUCTION; STOMACH CANCER; SURVIVAL RATE; TREATMENT PLANNING; TUMOR GROWTH;

CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROGNOSIS; S100 PROTEINS;

EID: 21244446530     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602613     Document Type: Short Survey

References (41)

1. Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E, Georgiev G, Berezin V, Bock E, Rygaard J, Cao R, Yihai Cao Y, Lukanidin E (2001) The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 20: 4685-4695
2. Ambartsumian N, Grigorian M, Larse I, Karlstrøm O, Sidenius N, Rygaard J, Georgiev G, Lukanidin E (1996) Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts 1 gene. Oncogene 13: 1621-1630
3. Belot N, Pochet R, Heizmann CW, Kiss R, Decaestecker C (2002) Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. BBA 1600: 74-83
4. Bjornland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM (1999) S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res 59: 4702-4708
5. Chen H, Fernig DG, Rudland PS, Sparks A, Wilkinson MC, Barraclough R (2001) Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun 286(5): 1212-1217
6. Cho YG, Nam SW, Kim TY, Kim YS, Kim CJ, Park JY, Lee JH, Kim HS, Lee JW, Park CH, Song YH, Lee SH, Yoo NJ, Lee JY, Park WS (2003) Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer. APMIS 111(5): 539-545
7. Cui JF, Liu YK, Pan BS, Song HY, Zhang Y, Sun RX, Chen J, Feng JT, Tang ZY, Yu YL, Shen HL, Yang PY (2004) Differential pmteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J Cancer Res Clin Oncol 130(10): 615-622
8. Davies BR, Davies MP, Gibbs FE, Barraclough R, Rudland PS (1993) Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene 8: 999-1008
9. Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P, Barraclough R (1996) Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene 13(8): 1631-1637
10. Ebralidze A, Tulchinsky E, Grigorian M, Afanasyeva A, Senin V, Revazova E, Lukanidin E (1989) Isolation and characterization of a gene specifically expressed 12 in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Dev 3: 1086-1093
11. El-Naaman C, Grum-Schwensen B, Mansouri A, Grigorian M, Santoni-Rugiu E, Hansen T, Kriajevska M, Schafer BW, Heizmann CW, Lukanidin E, Ambartsumian N (2004) Cancer predisposition in mice deficient for the metastasis-associated Mts 1 (S100A4) gene. Oncogene 23(20): 3670-3680
12. Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N, Christensen A, Selivanova G, Lukanidin E (2001) Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction. J Biol Chem 276: 22699-22708
13. Grigorian MS, Tulchinsky EM, Zain S, Ebralidze AK, Kramerov DA, Kriajevska MV, Georgiev GP, Lukanidin EM (1993) The mts1 gene and control of tumor metastasis. Gene 135(1-2): 229-238
14. Grum-Schwensen B, Klingelhofer J, Berg CH, El-Naaman C, Grigorian M, Lukanidin E, Ambartsumian N (2005) Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts 1) gene. Cancer Res (in press)
15. Heman R, Fasheh R, Calabrese C, Frank AJ, Maclean KH, Allard D, Barraclough R, Gilbertson RJ (2003) ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma. Cancer Res 63(1): 140-148
16. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM (1999) RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901
17. Hsieh HL, Schafer B, Weigle B, Heizmann CW (2004) S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells. Biochem Biophys Res Commun 316: 949-995
18. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H (2000) Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem 275: 40096-40105
19. Kim E, Helfman DM (2003) Characterization of the metastasis associated protein, S100A4: Roles of calcium-binding and dimerization in cellular localization and interaction with myosin. J Biol Chem 278: 30063-30073
20. Kriajevska MV, Cardenas MN, Grigorian MS, Ambartsumian NS, Georgiev GP, Lukanidin EM (1994) Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene. J Biol Chem 269: 19679-19682
21. Kriajevska M, Tarabykina S, Bronstein I, Maitland N, Lomonosov M, Hansen K, Georgiev G, Lukanidin E (1998) Metastasis-associated Mts 1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin. J Biol Chem 273: 9852-9856
22. Kriajevska M, Fischer-Larsen M, Moertz E, Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N, Lukanidin E (2002) Liprin beta 1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-associated protein S100A4 (Mts 1). J Biol Chem 277: 5229-5235
23. Lakshmi MS, Parker C, Sherbert GV (1993) Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behaviour of tumours. Anticancer Res 13: 299-304
24. Lee WY, Su WC, Lin PW, Guo HR, Chang TW, Chen HH (2004) Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology 66(6): 429-438
25. Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Florenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O (1996) Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts 1) ribozyme. Cancer Res 56: 5490-5498
26. Mazzucchelli L (2002) Protein S100A4: too long overlooked by pathologists? Am J Pathol 160(1): 7-13
27. Missiaglia E, Blaveri E, Terris B, Wang YH, Costello E, Neoptolemos JP, Crnogorac-Jurcevic T, Lemoine NR (2004) Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer 112(1): 100-112
28. Murakami N, Kotula L, Hwang YW (2000) Two distinct mechanisms for regulation of nonmuscle myosin assembly via the heavy chain: phosphorylation for MIIB and mts 1 binding for MIIA. Biochemistry 39: 11441-11451
29. Novitskaya V, Grigorian M, Kriajevska M, Tarabikina S, Bronstein I, Berezin V, Bock E, Lukanidin E (2000) Oligomeric forms of the metastasis-related Mts 1 (S100A4) protein stimulate neuronal differentiation in cultures of rat hippocampal neurons. J Biol Chem 275: 41278-41286
30. Pedersen MV, Kohler LB, Grigorian M, Novitskaya V, Bock E, Lukanidin E, Berezin V (2004) The Mts1/S100A4 protein is a neuroprotectant. J Neurosci Res 77(6): 777-786
31. Pedersen KB, Nesland JM, Fodstad O, Maelandsmo GM (2002) Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies. Br J Cancer 87(11): 1281-1286
32. Pedersen KB, Andersen K, Fodstad Ø, Maelandsmo GM (2004) Sensitization of interferon-γ induced apoptosis in human osteosarcoma cells by extracellular S100A4. BMC Cancer 4: 52
33. Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L, Barraclough R (2000) Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 60: 1595-1603
34. Schmidt-Hansen B, Klingelhofer J, Grum-Schwensen B, Christensen A, Andresen S, Kruse C, Hansen T, Ambartsumian N, Lukanidin E, Grigorian M (2004a) Functional significance of metastasis-inducing S100A4(Mts1) in tumor-stroma interplay. J Biol Chem 279: 24498-24504
35. Schmidt-Hansen B, Ornas D, Grigorian M, Klingelhofer J, Tulchinsky E, Lukanidin E, Ambartsumian N (2004b) Extracellular S100A4 (mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 23: 5487-5495
36. Takenaga K, Nakamura Y, Endo H, Sakiyama S (1994a) Involvement of S100-related calcium-binding protein pEL98 (or mts 1) in cell motility and tumor cell invasion. Jpn J Cancer Res 85: 831-839
37. Takenaga K, Nakamura Y, Sakiyama S, Hasegawa Y, Sato K, Endo H (1994b) Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin. J Cell Biol 124: 757-768
38. Tarabykina S, Kriajevska M, Scott DJ, Hill TJ, Lafitte D, Derrick PJ, Dodson GG, Lukanidin E, Bronstein I (2000) Heterocomplex formation between metastasis-related protein S100A4 (Mts 1) and S100A1 as revealed by the yeast two-hybrid system. FEBS Lett 475: 187-191
39. Wang G, Rudland PS, White MRH, Barraclough R (2000) Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1. J Biol Chem 275: 11141-11146
40. Wang G, Zhang S, Fernig DG, Martin-Fernandez M, Rudland PS, Barraclough R (2005) Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes. Oncogene 24(8): 1445-1454
41. Watanabe YN, Usada H, Minami T, Morita S-i, Tsugane R, Ishikawa K, Kohama Y, Tomida, Hidaka H (1993) Calvasculin as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src gene. FEBS Lett 324: 51-55